D5.2 Pre-processing tools

Dec 7, 2022 | Deliverables

ProCAncerI aims to develop novel AI models in order to add precision in the management of
prostate cancer patients by providing diagnostic tools able to reduce overdiagnosis and
overtreatment. To this end, a unique dataset from the project’s clinical sites is being assembled
making sure that image diversity and variability is properly addressed, which would enhance
models’ generalizability. That said, most current multicentric studies employ harmonization
methods either in centralized or federated architectures since it is still impossible to control or
predict all sources of variation. It should be stressed that there is currently no gold standard to
harmonize imaging data in a multicentric setting towards an optimal radiomics pipeline. Instead,
there are research trends that have shown promising results based on which the ProCAncerI
consortium has implemented a number of preprocessing functionalities that can be used to
experiment and optimize the ProCAncerI AI modeling tasks (Deep Learning and Radiomics
based).

Highlights

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Twitter feed is not available at the moment.

Stay in touch!